• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Lumenis appoints new general manager of its aesthetic business

Author(s):

Lumenis Ltd. announced that Roy Ramati has been appointed as the new general manager of the company’s Aesthetic Business Unit.

Lumenis Ltd. announced that Roy Ramati has been appointed as the new general manager of the company’s Aesthetic Business Unit.

“Mr. Ramati is the ideal candidate to lead our Aesthetic Business Unit. He has the strategic view and proven track record of transforming businesses to leverage the huge potential which our business has,” said Tzipi Ozer-Armon, CEO of Lumenis.

Mr. Ramati’s previous roles include: vice president and general manager, Enterprise Division at SanDisk; vice president operations and manager of the Memory Cards Business at Msystems; and founder and co-CEO of Fantine Group, a provider of business development services in Europe. Mr. Ramati also served as a management consultant at Shaldor, Israel's top management consulting firm.

Mr. Ramati holds an M.B.A. from the London Business School and a B.A. from Tel Aviv University.

"I am excited about joining the company, and look forward to leveraging my technology, marketing and management experience to further strengthen the Lumenis brand, introduce new solutions into the market, and reinforce connections with our customers and partners,” Mr. Ramati said.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.